THE INFLUENCE OF PHENOXYBENZAMINE AND ISOPROPYLMETHOXAMINE (BW 61-43) ON SOME CARDIOVASCULAR, METABOLIC, AND HISTOPATHOLOGIC EFFECTS OF NOREPINEPHRINE INFUSIONS IN DOGS.
D000311:Adrenal Glands; D001786:Blood Glucose; D001795:Blood Pressure Determination; D004285:Dogs; D004562:Electrocardiography; D005989:Glycerides; D006400:Hematocrit; D002479:Inclusion Bodies; D007770:L-Lactate Dehydrogenase; D008055:Lipids / Q000097:blood*; D008099:Liver; D008729:Methoxamine / Q000031:analogs & derivatives; D009638:Norepinephrine; D010496:Pericardium; D010600:Pharmacology; D010643:Phenoxybenzamine; D012106:Research; D013565:Sympatholytics; D014116:Toxicology
D001786:Blood Glucose; D005989:Glycerides; D008055:Lipids; D013565:Sympatholytics; D010643:Phenoxybenzamine; C038941:isopropylmethoxamine; D007770:L-Lactate Dehydrogenase; D008729:Methoxamine; D009638:Norepinephrine
ADRENAL GLANDS; BLOOD LIPIDS; BLOOD PRESSURE DETERMINATION; BLOOD SUGAR; DOGS; ELECTROCARDIOGRAPHY; EXPERIMENTAL LAB STUDY; GLYCERIDES; HEMATOCRIT; INCLUSION BODIES; LACTATE DEHYDROGENASE; LIVER; NOREPINEPHRINE; PERICARDIUM; PHARMACOLOGY; PHENOXYBENZAMINE; SYMPATHOLYTICS; TOXICOLOGIC REPORT